Search research articles
Contact Us
Filters
Showing results (61-70 of 99) with videos related to
Page
of 10
Sort By:
Annals of Diagnostic Pathology
|
September 25, 2020
Lymphoid enhancer binding factor 1 (LEF1) expression is significantly higher in Hodgkin lymphoma associated with Richter syndrome relative to de novo classic Hodgkin lymphoma
Kirill A Lyapichev, Ali Sakhdari, Joseph D Khoury, et al.
Cancer Medicine
|
December 6, 2019
RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD
Ali Sakhdari, Beenu Thakral, Sanam Loghavi, et al.
Archives of Pathology & Laboratory Medicine
|
June 16, 2025
Technical and Clinical Validity of Assessing Measurable Residual Disease by Multicolor Flow Cytometry in an Unselected Acute Myeloid Leukemia Patient Cohort
Sa A Wang, Shaoying Li, Wei Wang, et al.
Human Pathology
|
October 16, 2022
Lymphoplasmacytic lymphoma with IgG or IgA paraprotein: a study of 29 cases including cases that can mimic plasma cell neoplasms
Lianqun Qiu, Okechukwu V Nwogbo, L Jeffrey Medeiros, et al.
Leukemia & Lymphoma
|
September 20, 2019
<i>De novo</i> CD5+ diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab era
Bei Hu, Loretta J Nastoupil, Sanam Loghavi, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 1, 2024
Expression of CD6 in Aggressive NK/T-cell Neoplasms and Assessment as a Potential Therapeutic Target: A Bone Marrow Pathology Group Study
Xiaoxian Zhao, Chad M McCall, Jared G Block, et al.
Archives of Pathology & Laboratory Medicine
|
December 23, 2024
The Significance of Detecting an Unusual Myeloblast Immunophenotype in a Presumptive Clinical Diagnosis of Myelodysplastic Syndromes
Fnu Sameeta, Wei Wang, Fatima Zahra Jelloul, et al.
Frontiers in Oncology
|
November 16, 2020
Emergence of <i>BCR</i>-<i>ABL1</i> Fusion in AML Post-FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance - A Case Series
Ahmad S Alotaibi, Musa Yilmaz, Sanam Loghavi, et al.
Blood Cancer Journal
|
August 28, 2020
Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features
Wen Shuai, Pei Lin, Paolo Strati, et al.
The American Journal of Surgical Pathology
|
July 25, 2022
MUM1/IRF4 is Highly Expressed in Dermatopathic Lymphadenopathy: Potential Utility in Diagnosis and Differential Diagnosis
Sofia Garces, Zbigniew Rudzki, C Cameron Yin, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 99) with videos related to
Sort By:
Page
of 10
Annals of Diagnostic Pathology
|
September 25, 2020
Lymphoid enhancer binding factor 1 (LEF1) expression is significantly higher in Hodgkin lymphoma associated with Richter syndrome relative to de novo classic Hodgkin lymphoma
Kirill A Lyapichev, Ali Sakhdari, Joseph D Khoury, et al.
Cancer Medicine
|
December 6, 2019
RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD
Ali Sakhdari, Beenu Thakral, Sanam Loghavi, et al.
Archives of Pathology & Laboratory Medicine
|
June 16, 2025
Technical and Clinical Validity of Assessing Measurable Residual Disease by Multicolor Flow Cytometry in an Unselected Acute Myeloid Leukemia Patient Cohort
Sa A Wang, Shaoying Li, Wei Wang, et al.
Human Pathology
|
October 16, 2022
Lymphoplasmacytic lymphoma with IgG or IgA paraprotein: a study of 29 cases including cases that can mimic plasma cell neoplasms
Lianqun Qiu, Okechukwu V Nwogbo, L Jeffrey Medeiros, et al.
Leukemia & Lymphoma
|
September 20, 2019
<i>De novo</i> CD5+ diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab era
Bei Hu, Loretta J Nastoupil, Sanam Loghavi, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 1, 2024
Expression of CD6 in Aggressive NK/T-cell Neoplasms and Assessment as a Potential Therapeutic Target: A Bone Marrow Pathology Group Study
Xiaoxian Zhao, Chad M McCall, Jared G Block, et al.
Archives of Pathology & Laboratory Medicine
|
December 23, 2024
The Significance of Detecting an Unusual Myeloblast Immunophenotype in a Presumptive Clinical Diagnosis of Myelodysplastic Syndromes
Fnu Sameeta, Wei Wang, Fatima Zahra Jelloul, et al.
Frontiers in Oncology
|
November 16, 2020
Emergence of <i>BCR</i>-<i>ABL1</i> Fusion in AML Post-FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance - A Case Series
Ahmad S Alotaibi, Musa Yilmaz, Sanam Loghavi, et al.
Blood Cancer Journal
|
August 28, 2020
Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features
Wen Shuai, Pei Lin, Paolo Strati, et al.
The American Journal of Surgical Pathology
|
July 25, 2022
MUM1/IRF4 is Highly Expressed in Dermatopathic Lymphadenopathy: Potential Utility in Diagnosis and Differential Diagnosis
Sofia Garces, Zbigniew Rudzki, C Cameron Yin, et al.
Page
of 10